Tag Archives: Company

5 Things You Need to Know About Marijuana Stock Zynerba Pharmaceuticals

5 Things You Need to Know About Marijuana Stock Zynerba Pharmaceuticals

5 Things You Need to Know About Marijuana Stock Zynerba Pharmaceuticals

There are three different general types of marijuana stocks on the market. Some are marijuana growers. Others provide supplies to marijuana growers. Then there’s the third type: the biotechs. Zynerba Pharmaceuticals belongs to the last kind of marijuana stock.

Cara Therapeutics Stock Has Lost More Than Half Its Value in 2 Weeks

Cara Therapeutics Stock Has Lost More Than Half Its Value in 2 Weeks

On June 27, Cara Therapeutics (NASDAQ:CARA), a clinical-stage biotech company with a focus on treating chronic pain and pruritus, surged to an all-time intraday high of $28.50 a share. Cara was just $73 million away from joining the $1 billon market cap ranks.

Better Know a Marijuana Stock: MedReleaf Corp.

Better Know a Marijuana Stock: MedReleaf Corp.

MedReleaf is one of less than four dozen licensed producers and retailers of medical cannabis products in Canada. The company was founded just four years ago, and it focuses on supplying dried cannabis, cannabis oils, and cannabis oil capsules to qualified medical patients in Canada.

Aurora Cannabis Inc. Is Making a Push into Hemp: Is it a Good Idea?

Aurora Cannabis Inc. Is Making a Push into Hemp: Is it a Good Idea?

Aurora Cannabis Inc. today is one of the pre-eminent marijuana producers listed on the TSX Venture Exchange with a market capitalization just shy of $750 million, making it the fourth-largest marijuana stock behind only GW Pharmaceuticals PLC- ADR, Canopy Growth Corp., and Aphria Inc.

Better Know a Marijuana Stock: Arena Pharmaceuticals

Better Know a Marijuana Stock: Arena Pharmaceuticals

Unlike GW Pharmaceuticals and Zynerba Pharmaceuticals, which rely on cannabinoid-based medicines to fill out the entirety of their drug-development pipelines, Arena Pharmaceuticals is one of the drug developers that have some of their pipelines devoted to cannabinoid-type therapeutics or CB agonists and other portions devoted to non-cannabinoid medicines.

If Warren Buffett Were to Buy 1 Marijuana Stock, it Would Be Aphria Inc.

If Warren Buffett Were to Buy 1 Marijuana Stock, it Would Be Aphria Inc.

Warren Buffett is well known as the most successful investor of all time. Buffett spent his formative years under the tutelage of Benjamin Graham, who is known today as the “father of value investing.” Let’s see whether or not Aphria Inc. can pass Buffett’s mentor’s criteriea test.

Medical Marijuana Delivered Directly to Customers From Eaze

Medical Marijuana Delivered Directly to Customers From Eaze

As California’s medical marijuana industry has grown to an $800 million dollar business, one company is hoping to take advantage of that by delivery the product directly to the customer.

Here’s Why Emerging Marijuana Stock Cara Therapeutics Inc. Surged

Here’s Why Emerging Marijuana Stock Cara Therapeutics Inc. Surged

Shares of Cara Therapeutics Inc., a clinical-stage biotech company with a focus on treating pain and pruritus, rocketed higher by as much as 11% during Wednesday’s trading session after providing an update to its phase 3 trial involving kappa opioid receptor agonist CR845.

New York Cannabis Company Valley Agriceuticals Sold for $17 Million

New York Cannabis Company Valley Agriceuticals Sold for $17 Million

Multi-state cannabis company iAnthus Capital Management has now planted its flag in New York with Monday’s announced acquisition of Valley Agriceuticals.

Which Cannabis Stock Could Be First to $1 Billion in Annual Sales?

Which Cannabis Stock Could Be First to $1 Billion in Annual Sales?

If there is a “Holy Grail” milestone out there for cannabis stocks, it’s the $1 billion sales mark. The first cannabis company to hit $1 billion in sales will likely validate the industry to Wall Street and investors. But which marijuana stock has the best chance at being first to $1 billion in annual sales?

Aurora Cannabis eyes expansion with legalization on the horizon

Aurora Cannabis Eyes Expansion With Legalization on the Horizon

As Canada heads toward legalization of marijuana, Alberta producer Aurora Cannabis is focused on expansion with ambitions to raise a $160-million “war chest” from investors who are anxious to profit from what is expected to be a multibillion industry.

California Cannabis Business Expo: Stimulating Trade Show in March

California Cannabis Business Expo: Stimulating Trade Show

Are you concerned about the pedigree of cannabis investment management? If so, just take a good look at the management at MJIC. MJIC is a holding company deploying a diversified business plan in the legal cannabis industry.

Canopy Growth Corp. Has Entered a New Realm

Canopy Growth Corp. Has Entered a New Realm

There are a number of big institutions, including mutual funds, pension funds, and investment banks, that use the TSX Composite and its sub-indices as performance benchmarks for their portfolios. The addition of Canopy to the index will introduce some new dimensions to the index’s performance.

Medical cannabis company ready to expand in Maryland

Medical Cannabis Company Ready to Expand in Maryland

Maryland’s medical cannabis program is expected to be fully up and running later this year, and in the coming months, patients can register with the state. But there’s a series of issues that still need to be resolved, even as marijuana growers and dispensaries are getting ready to open for business.

Aurora Cannabis Inc Remains a Top Cannabis Pick

Aurora Cannabis Inc Remains a Top Cannabis Pick

Investors are becoming more and more impressed with the job CEO Terry Booth and his team are doing at Aurora Cannabis Inc. After posting strong Q2 results and closing a C$75 million financing, there’s a lot to like with company.

Can This Marijuana Stock Add Some Green to Your Portfolio?

Can This Marijuana Stock Add Some Green to Your Portfolio?

Investors in cannabis companies had an eventful 2016 with the approval of recreational marijuana usage in the states of California, Massachusetts, Maine, and Nevada providing a boost to all sorts of marijuana stocks. Of particular note, shares of Corbus Pharmaceuticals (NASDAQ: CRBP) posted a whopping 600% gain in 2016 following positive phase 2 data.

Can Aphria Inc. Challenge Canopy Growth Corp.’s Dope Dominance?

Can Aphria Inc. Challenge Canopy Growth Corp.’s Dope Dominance?

Canopy Growth Corp. has garnered the most attention and established itself as the market leader; however, there is another company in the Canadian marijuana industry that could emerge as a potential winner.


Page 1 of 212
Top